Briana C. Prager

6.8k total citations · 3 hit papers
32 papers, 2.9k citations indexed

About

Briana C. Prager is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Briana C. Prager has authored 32 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Briana C. Prager's work include Glioma Diagnosis and Treatment (7 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (5 papers). Briana C. Prager is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (5 papers). Briana C. Prager collaborates with scholars based in United States, China and Denmark. Briana C. Prager's co-authors include Jeremy N. Rich, Qi Xie, Shideng Bao, Christopher G. Hubert, Qiulian Wu, Stephen C. Mack, Xiuxing Wang, Shruti Bhargava, Andrew E. Sloan and Ryan C. Gimple and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Briana C. Prager

32 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo

2016 462 citations Christopher G. Hubert, Maricruz Rivera et al. Cancer Research profile →
Cancer Stem Cells: The Architects of the Tumor Ecosystem

2019 413 citations Briana C. Prager, Qi Xie et al. profile →
The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells

2020 274 citations Deobrat Dixit, Briana C. Prager et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Briana C. Prager United States	20	1.7k	919	827	589	379	32	2.9k
Ryan C. Gimple United States	21	1.6k 0.9×	510 0.6×	798 1.0×	433 0.7×	159 0.4×	32	2.4k
Erin E. Mulkearns-Hubert United States	18	1.3k 0.7×	729 0.8×	602 0.7×	662 1.1×	207 0.5×	26	2.3k
Xiangqi Meng China	23	1.2k 0.7×	379 0.4×	692 0.8×	310 0.5×	101 0.3×	59	2.0k
John J. Tentler United States	29	1.5k 0.9×	1.3k 1.4×	608 0.7×	93 0.2×	252 0.7×	79	3.1k
Christoph P. Beier Denmark	30	1.6k 0.9×	1.4k 1.6×	1.0k 1.2×	1.3k 2.2×	313 0.8×	82	3.9k
Elsa Quintana United States	18	1.6k 1.0×	2.1k 2.2×	964 1.2×	186 0.3×	330 0.9×	40	3.5k
Allegra A. Petti United States	22	1.7k 1.0×	942 1.0×	339 0.4×	151 0.3×	169 0.4×	30	3.3k
Stephen Meek United Kingdom	18	2.4k 1.4×	407 0.4×	334 0.4×	672 1.1×	114 0.3×	29	3.8k
Svetlana Kotliarova United States	21	2.2k 1.3×	1.2k 1.3×	880 1.1×	1.2k 2.0×	260 0.7×	26	3.6k
Shuli Xia United States	29	1.7k 1.0×	496 0.5×	497 0.6×	424 0.7×	116 0.3×	66	2.6k

Countries citing papers authored by Briana C. Prager

Since Specialization

Citations

This map shows the geographic impact of Briana C. Prager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Briana C. Prager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Briana C. Prager more than expected).

Fields of papers citing papers by Briana C. Prager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Briana C. Prager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Briana C. Prager. The network helps show where Briana C. Prager may publish in the future.

Co-authorship network of co-authors of Briana C. Prager

This figure shows the co-authorship network connecting the top 25 collaborators of Briana C. Prager. A scholar is included among the top collaborators of Briana C. Prager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Briana C. Prager. Briana C. Prager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gimple, Ryan C., Guoxin Zhang, Shuai Wang, et al.. (2023). Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting. JCI Insight. 8(6). 10 indexed citations

Lv, Deguan, Cuiqing Zhong, Deobrat Dixit, et al.. (2023). EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma. Molecular Cell. 83(23). 4334–4351.e7. 36 indexed citations

Chaim, Olga Meiri, Shunichiro Miki, Briana C. Prager, et al.. (2023). Gα12 signaling regulates transcriptional and phenotypic responses that promote glioblastoma tumor invasion. Scientific Reports. 13(1). 22412–22412. 5 indexed citations

Dixit, Deobrat, Briana C. Prager, Ryan C. Gimple, et al.. (2022). Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases. Science Translational Medicine. 14(626). eabf3917–eabf3917. 19 indexed citations

Bernareggi, Davide, Qi Xie, Briana C. Prager, et al.. (2022). CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity. Nature Communications. 13(1). 1899–1899. 46 indexed citations

Lee, Derrick, Ryan C. Gimple, Xujia Wu, et al.. (2022). Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling. Journal of Clinical Investigation. 133(2). 22 indexed citations

Lv, Deguan, Ryan C. Gimple, Cuiqing Zhong, et al.. (2022). PDGF signaling inhibits mitophagy in glioblastoma stem cells through N-methyladenosine. Developmental Cell. 57(12). 1466–1481.e6. 54 indexed citations

Kfoury, Najla, Zongtai Qi, Briana C. Prager, et al.. (2021). Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma. Proceedings of the National Academy of Sciences. 118(16). 28 indexed citations

Xia, Zhen, Min Tang, Jiayan Ma, et al.. (2021). Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase. Nucleic Acids Research. 49(13). 7361–7374. 88 indexed citations

10.

Shakya, Sajina, Anthony D. Gromovsky, James S. Hale, et al.. (2021). Altered lipid metabolism marks glioblastoma stem and non-stem cells in separate tumor niches. Acta Neuropathologica Communications. 9(1). 81 indexed citations

11.

Sen, Arko, Briana C. Prager, Cuiqing Zhong, et al.. (2021). Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma. Cancer Research. 82(3). 377–390. 6 indexed citations

12.

Wang, Dongrui, Briana C. Prager, Ryan C. Gimple, et al.. (2020). CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies. Cancer Discovery. 11(5). 1192–1211. 121 indexed citations

13.

Dixit, Deobrat, Briana C. Prager, Ryan C. Gimple, et al.. (2020). The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells. Cancer Discovery. 11(2). 480–499. 274 indexed citations breakdown →

14.

Prager, Briana C., Shruti Bhargava, Vaidehi Mahadev, Christopher G. Hubert, & Jeremy N. Rich. (2020). Glioblastoma Stem Cells: Driving Resilience through Chaos. Trends in cancer. 6(3). 223–235. 265 indexed citations

15.

Dong, Zhen, Guoxin Zhang, Meng Qu, et al.. (2019). Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock. Cancer Discovery. 9(11). 1556–1573. 217 indexed citations

16.

Zhang, Guoxin, Zhen Dong, Briana C. Prager, et al.. (2019). Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC. JCI Insight. 4(7). 32 indexed citations

17.

Jin, Xun, Leo J.Y. Kim, Qiulian Wu, et al.. (2017). Targeting glioma stem cells through combined BMI1 and EZH2 inhibition. Nature Medicine. 23(11). 1352–1361. 258 indexed citations

18.

Jin, Xun, Leo A. Kim, Qiulian Wu, et al.. (2017). EXTH-37. TARGETING GLIOMA STEM CELLS THROUGH COMBINED BMI1 AND EZH2 INHIBITION. Neuro-Oncology. 19(suppl_6). vi80–vi80. 1 indexed citations

19.

Zhu, Zhe, Matthew J. Gorman, Lisa D. McKenzie, et al.. (2017). Zika virus has oncolytic activity against glioblastoma stem cells. The Journal of Experimental Medicine. 214(10). 2843–2857. 167 indexed citations

20.

Hubert, Christopher G., Maricruz Rivera, Lisa C. Spangler, et al.. (2016). A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. Cancer Research. 76(8). 2465–2477. 462 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact